Quantitative Benefit-Risk Assessment in Medical...

By Staff Writer

April 19, 2023

Benefit-risk assessment is a crucial step in evaluating the safety and efficacy of medical products. Quantitative benefit-risk assessment (qBRA) is a set of techniques that can help drug and medical device developers and regulators to evaluate the...
Zambia’s National Health Insurance Making Progress Towards Strategic Pu...
Chronic Heart Failure: PBAC Recommends Empagliflozin
Global Pull Incentive Needed to Future-Proof Antibiotic Innovation, Says OHE ...
Medscheme released updated MEDICINE EXCLUSION LIST APRIL 2023
Genedrive MT-RNR1 ID Kit to detect genetic variation and protect hearing in b...
Did CVDs recover post COVID-19 ?
Boosting local medicine production in Uganda: How import fees are affecting t...
Multiple myeloma is the second most common type of blood cancer, with approxi...
The evidence for Cannabidiol is building
HTA must consider health equity for progress
Mobocertinib added in NICE guidelines
Comprehensive Review of Methods to Assess Uncertainty in Health Economic Eval...